Related Experiment Videos
Antibiotic-associated neutropenia
1Wright State University School of Medicine, Dayton, Ohio.
Abstract:
Neutropenia is an uncommon but potentially serious complication of drug therapy. Many drugs, especially antibiotics, can produce this untoward effect. Typically, drug-induced neutropenia occurs in a patient receiving a semisynthetic penicillin for two weeks or more. The cause is believed to be either a hypersensitivity reaction or a toxic dose-related suppression of white blood cell precursors. Most patients improve after discontinuation of the drug.
Insights
Drug-induced neutropenia, often linked to semisynthetic penicillins, is a serious side effect. Discontinuing the medication typically resolves this condition, improving white blood cell counts.
Area of Science:
- Pharmacology
- Hematology
- Toxicology
Background:
- Drug-induced neutropenia is a rare but significant adverse effect of various medications.
- Antibiotics, particularly semisynthetic penicillins, are frequently implicated in its development.
Observation:
- Neutropenia commonly manifests after two weeks of continuous semisynthetic penicillin therapy.
- The condition involves a decrease in neutrophils, a type of white blood cell.
Findings:
- The etiology is hypothesized to involve either a hypersensitivity immune response or direct toxicity to bone marrow precursors.
- Most cases of drug-induced neutropenia resolve upon cessation of the causative agent.
Implications:
- Awareness of drug-induced neutropenia is crucial for clinicians managing patients on relevant medications.
- Prompt identification and discontinuation of offending drugs can prevent severe complications and facilitate recovery.